United States · FDA National Drug Code directory

Lym Combination

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 43742-1787_582e4d54-3964-415d-beaf-bed5b109c868
Product NDC: 43742-1787
Form: LIQUID
Composition / generic term: Anaplasma Phagocytophilum, Babesia Microti, Bartonella Henselae, Borrelia Burgdorferi Nosode, Ehrlichia Nosode (Canine), Mycoplasma Pneumoniae, Morbillinum, Meningococcus Nosode, Hepatitis B Nosode
Labeler: Deseret Biologicals, Inc.
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start / end (source format): 20210514
Source listing expiry: 20261231

Source-listed ingredients

ANAPLASMA PHAGOCYTOPHILUM — 15 [hp_X]/mL
BABESIA MICROTI — 15 [hp_X]/mL
BARTONELLA HENSELAE — 15 [hp_X]/mL
BORRELIA BURGDORFERI — 15 [hp_X]/mL
EHRLICHIA CANIS — 15 [hp_X]/mL
MYCOPLASMA PNEUMONIAE — 15 [hp_X]/mL
MEASLES VIRUS — 16 [hp_X]/mL
NEISSERIA MENINGITIDIS — 27 [hp_X]/mL
HEPATITIS B VIRUS — 15 [hp_C]/mL

These values do not establish equivalence or a dose recommendation.

Packages

30 mL in 1 BOTTLE, DROPPER (43742-1787-1) · 43742-1787-1

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →